Skip to main content

CorMedix Inc.

CRMD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001410098

No open-market purchases or sales by CorMedix Inc. insiders were filed in the last 90 days; 193 institutions reported holding it in 13F filings for Q2 2026, worth $345.5M in total; no superinvestor holds it.

Q4 2021 vs. Q3 2021

How the institutions holding CorMedix Inc. changed between Q3 2021 and Q4 2021.

All holders in Q4 2021All holders in Q3 2021

13F holders of CRMD: Q3 2021 compared with Q4 2021
MeasureQ3 2021Q4 2021Change
Holders7980+1
Shares11.8M13.0M+1.24M (+10.5%)
Value$55.0M$59.4M+$4.44M (+8.1%)

New holders (7)

Institutions that held CorMedix Inc. at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to CRMD in Q4 2021
InstitutionSharesValue% of portfolio
Jump Financial, LLC27,400$124.0K0.01%
Manufacturers Life Insurance Company, The19,218$87.0K0.00%
Dimensional Fund Advisors LP17,903$81.0K0.00%
Walleye Capital LLC11,200$51.0K0.00%
Nisa Investment Advisors, LLC7,414$31.0K0.00%
Zullo Investment Group, Inc.850$4.00K0.00%
Cornerstone Advisory, LLC5$00.00%

Sold out (6)

Institutions that held CorMedix Inc. at the end of Q3 2021 and filed for Q4 2021 without it.

Institutions that sold out of CRMD in Q4 2021
InstitutionShares, Q3 2021Value, Q3 2021
Renaissance Technologies LLC118,001$549.0K
Wolverine Trading, LLC21,781$101.0K
Price T Rowe Associates Inc17,527$82.0K
Beacon Pointe Advisors, LLC12,000$56.0K
Avestar Capital, LLC10,000$47.0K
Group One Trading, L.P.3,068$14.0K